Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Mar 2005

Toyoda Hidenori, Kumada Takashi, Kiriyama Seiki, Sone Yasuhiro, Tanikawa Makoto, Hisanaga Yasuhiro, Kuzuya Teiji, Honda Takashi, Hayashi Kazuhiko, Nakano Isao, Katano Yoshiaki, Goto Hidemi

Abstract excerpt

BACKGROUND: Changes in hepatitis C virus (HCV) antibody status were followed for 10 years after the eradication of HCV by interferon (IFN) therapy in 30 patients with chronic hepatitis C who showed a sustained virological response. METHODS: HCV core antibody titer, third-generation HCV recombinant immunoblot assay (RIBA) grade (measuring the presence of antibodies for core, NS3, NS4, and NS5 antigens), and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C Antibodies

Share to Hepatitis C, Chronic

Share to Interferons

Share to RNA, Viral

Share to Time Factors

Share to Viral Core Proteins

Source

Identifiers

PMID: 15736006
DOI: 10.1086/428128

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.PMID 15736006Read ↗

Durability of serological remission in chronic hepatitis C treated with interferon-alpha-2B.Semantic proximity Read ↗

Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.Semantic proximity Read ↗

Prompt decrease of circulating hepatitis C virus in patients with chronic hepatitis C after treatment with interferon.Semantic proximity Read ↗

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.Semantic proximity Read ↗

Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitorsSemantic proximity Read ↗

Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: relation to viral genotype, cryoglobulinemia and response to interferon.Semantic proximity Read ↗

Genotype-dependent serologic reactivities in patients infected with hepatitis C virus in the United States.Semantic proximity Read ↗

Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome.Semantic proximity Read ↗

Presence of anti-interferon antibodies is not associated with non-response to pegylated interferon treatment in chronic hepatitis B.Semantic proximity Read ↗

Serum HCV RNA titer at the end of interferon therapy predicts the long-term outcome of treatment.Semantic proximity Read ↗

Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up.Semantic proximity Read ↗

Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C. Consensus Interferon Study Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.